NCT02101307 Multicenter, Post-marketing, Non-interventional, Observational Study in RA Patients Treated With RoActemra/Actemra (Tocilizumab) Status COMPLETED Phase N/A
NCT02100696 A Study of the Efficacy and Safety of Etrolizumab in Participants With Ulcerative Colitis Who Have Been Previously Exposed to Tumor Necrosis Factor (TNF) Inhibitors Status COMPLETED Phase PHASE3
NCT02100111 An Analysis of Treatment Patterns and Outcomes for Basal Cell Carcinoma (BCC) Cancer Participants Status COMPLETED Phase N/A
NCT02099656 A Study Evaluating the Effects of Lebrikizumab on Airway Eosinophilic Inflammation in Participants With Uncontrolled Asthma Status COMPLETED Phase PHASE2
NCT02098967 A Study of the Safety and Pharmacokinetics of RO6839921, An MDM2 Antagonist, in Patients With Advanced Cancers, Including Acute Myeloid Leukemia. Status COMPLETED Phase PHASE1
NCT02097810 Study of Oral RXDX-101 in Adult Patients With Locally Advanced or Metastatic Cancer Targeting NTRK1, NTRK2, NTRK3, ROS1, or ALK Molecular Alterations. Status COMPLETED Phase PHASE1
NCT02097745 A Study of the Efficacy and Safety of Re-treatments With Rituximab in Patients With Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Anti-tnfa Therapies Status COMPLETED Phase PHASE3
NCT02093026 Extension Study to Assess the Efficacy and Safety of Repeat Treatment With Rituximab (MabThera) in Participants With Active Rheumatoid Arthritis (RA) Status COMPLETED Phase PHASE2
NCT02093000 A Study Examining Maintenance Bevacizumab (Avastin®) Monotherapy in Participants With Advanced Lung Adenocarcinoma Status COMPLETED Phase N/A
NCT02091414 A Study of CellCept (Mycophenolate Mofetil) in Combination Therapy in Heart Transplant Patients. Status COMPLETED Phase PHASE3
NCT02081183 A Study to Evaluate Efficacy of CellCept (Mycophenolate Mofetil) in Patients With Lupus Nephritis Status TERMINATED Phase PHASE3
NCT02080884 An Observational Study Examining the Effect of Added MabThera Therapy in Patients With Untreated Chronic Lymphocytic Leukemia Status COMPLETED Phase N/A
NCT02079532 A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Had an Inadequate Response to a Single Anti-TNF Inhibitor Status COMPLETED Phase PHASE3
NCT02079519 A Study of Avastin (Bevacizumab) in Patients With Multiple Myeloma Status TERMINATED Phase PHASE2
NCT02075840 A Study Comparing Alectinib With Crizotinib in Treatment-Naive Anaplastic Lymphoma Kinase-Positive Advanced Non-Small Cell Lung Cancer Participants Status COMPLETED Phase PHASE3
NCT02074553 A Cross-over Study Examining the Bioequivalence of 3 Test Formulations to a Reference Formulation of Alectinib (RO5424802) in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT02073279 Efficacy and Safety Study of Satralizumab (SA237) as Monotherapy to Treat Participants With Neuromyelitis Optica (NMO) and Neuromyelitis Optica Spectrum Disorder (NMOSD) Status COMPLETED Phase PHASE3
NCT02071225 A Study Evaluating the Efficacy of Obinutuzumab and Bendamustine Treatment in Participants With Refractory or Relapsed Chronic Lymphocytic Leukemia Status COMPLETED Phase PHASE2
NCT02063412 Nursing and Pharmacy Care Between Capecitabine and 5-Fluoruracil Regimens Status WITHDRAWN Phase N/A